Gut microbiota, obesity and diabetes

Annales Nestle

Volumn 67, Issue 1, 2009, Pages 39-47

  Bibiloni, Rodrigo ^a   Membrez, Mathieu ^a   Chou, Chieh Jason ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Diabetes; Gut microbiota; Molecular based methods; Obesity

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; NEOMYCIN; NORFLOXACIN; PREBIOTIC AGENT; PROBIOTIC AGENT;

ARCHAEBACTERIUM; ARTICLE; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; DEVELOPED COUNTRY; DIABETES MELLITUS; ENERGY CONSERVATION; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; EPIDEMIC; FUNGUS; GEOGRAPHIC DISTRIBUTION; GLUCOSE HOMEOSTASIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH BEHAVIOR; HEREDITY; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTESTINE ABSORPTION; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LEAN BODY WEIGHT; MICROBIAL COMMUNITY; MICROFLORA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT UPTAKE; OBESITY; WORLD HEALTH ORGANIZATION;

EID: 63449102398     PISSN: 05178606     EISSN: 16614011     Source Type: Journal    
DOI: 10.1159/000187168     Document Type: Article

References (67)

1. Ogden CL, Carroll MD, Curtin LR, et al: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
2. Berghofer A, Pischon T, Reinhold T, et al: Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008; 8: 200.
3. www.idf.org.
4. Eckburg PB, Bik EM, Bernstein CN, et al: Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638.
5. Tannock GW: The intestinal microflora; in Fuller R, Perdigon G (eds): Gut Flora. Nutrition, Immunity and Health. Oxford, Blackwell Press, 2003, pp 1-23.
6. Miller TL, Wolin MJ: Stability of Methanobrevibacter smithii populations in the microbial flora excreted from the human large bowel. Appl Environ Microbiol 1983; 45: 317-318.
7. Simon GL, Gorbach SL: Intestinal flora in health and disease. Gastroenterology 1984; 86: 174-193.
8. Sghir A, Gramet G, Suau A, et al: Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 2000; 66: 2263-2266.
9. Harmsen HJ, Raangs GC, He T, et al: Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 2002; 68: 2982-2990.
10. Lay C, Rigottier-Gois L, Holmstrom K, et al: Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol 2005; 71: 4153-4155.
11. Suau A, Bonnet R, Sutren M, et al: Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999; 65: 4799-4807.
12. Hold G, Pryde S, Russel V, et al: Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol 2002;39:33-39.
13. Hayashi H, Sakamoto M, Benno Y: Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 2002; 46: 535-548.
14. Hayashi H, Sakamoto M, Kitahara M, Benno Y: Molecular analysis of fecal microbiota in elderly individuals using 16S rDNA library and T-RFLP. Microbiol Immunol 2003; 47: 557-570.
15. Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
16. Bibiloni R, Mangold M, Madsen KL, et al: The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006; 55: 1141-1149.
17. Frank DN, St Amand AL, Feldman RA, et al: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-13785.
18. Kassinen A, Krogius-Kurikka L, Makivuokko H, et al: The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33.
19. Kurokawa K, Itoh T, Kuwahara T, et al: Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 2007; 14: 169-181.
20. Andersson AF, Lindberg M, Jakobsson H, et al: Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE 2008; 3:e2836.
21. Sherman LA, Savage DC: Lipoteichoic acids in Lactobacillus strains that colonize the mouse gastric epithelium. Appl Environ Microbiol 1986; 52: 302-304.
22. Guan LL, Hagen KE, Tannock GW, et al: Detection and identification of Lactobacillus species in crops of broilers of different ages by using PCR-denaturing gradient gel electrophoresis and amplified ribosomal DNA restriction analysis. Appl Environ Microbiol 2003; 69: 6750-6757.
23. Konstantinov SR, Awati A, Smidt H, et al: Specific response of a novel and abundant Lactobacillus amylovorus -like phylotype to dietary prebiotics in the guts of weaning piglets. Appl Environ Microbiol 2004; 70: 3821- 3830.
24. Snart J, Bibiloni R, Grayson T, et al: Supplementation of the diet with high-viscosity beta-glucan results in enrichment for lactobacilli in the rat cecum. Appl Environ Microbiol 2006; 72: 1925-1931.
25. Zoetendal EG, Akkermans AD, de Vos WM: Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998; 64: 3854-3859.
26. Muyzer G, Smalla K: Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Antonie Van Leeuwenhoek 1998; 73: 127-141.
27. Tannock GW, Munro K, Bibiloni R, et al: Impact of consumption of oligosaccharidecontaining biscuits on the fecal microbiota of humans. Appl Environ Microbiol 2004; 70: 2129-2136.
28. Lim EL, Tomita AV, Thilly WG, Polz MF: Combination of competitive quantitative PCR and constant-denaturant capillary electrophoresis for high-resolution detection and enumeration of microbial cells. Appl Environ Microbiol 2001; 67: 3897-3903.
29. Seksik P, Rigottier-Gois L, Gramet G, et al: Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003; 52: 237-242.
30. Palmer C, Bik EM, Eisen MB, et al: Rapid quantitative profiling of complex microbial populations. Nucleic Acids Res 2006; 34:e5.
31. Tannock GW: New perceptions of the gut microbiota: implications for future research. Gastroenterol Clin North Am 2005; 34: 361-382, vii.
32. Egert M, de Graaf AA, Maathuis A, et al: Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing. FEMS Microbiol Ecol 2007; 60: 126-135.
33. Gill SR, Pop M, Deboy RT, et al: Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359.
34. Turnbaugh PJ, Ley RE, Hamady M, et al: The human microbiome project. Nature 2007; 449: 804-810.
35. Hill JO: Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev 2006; 27: 750-761.
36. Backhed F, Ding H, Wang T, et al: The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-15723.
37. Báckhed F, Manchester JK, Semenkovich CF, Gordon JI: Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007; 104: 979-984.
38. Ley RE, Backhed F, Turnbaugh P, et al: Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-11075.
39. Turnbaugh PJ, Ley RE, Mahowald MA, et al: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
40. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI: Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3: 213-223.
41. Gary SR, Woo KY: The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab Res Rev 2008; 24(suppl 1):S25-S30.
42. Beebe DK, Walley E: Diabetic diarrhea. An underdiagnosed complication? Postgrad Med 1992; 91: 179-186.
43. Emrich LJ, Shlossman M, Genco RJ: Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 1991; 62: 123-131.
44. Loe H: Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993; 16: 329-334.
45. Nelson RG, Shlossman M, Budding LM, et al: Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990; 13: 836-840.
46. Taylor GW, Burt BA, Becker MP, et al: Noninsulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 1998; 69: 76-83.
47. Amano A: Molecular interaction of Porphyromonas gingivalis with host cells: implication for the microbial pathogenesis of periodontal disease. J Periodontol 2003; 74: 90-96.
48. Demmer RT, Jacobs DR Jr, Desvarieux M: Periodontal disease and incident type 2 diabetes: results from the First National Health and Nutrition Examination Survey and its epidemiologic follow-up study. Diabetes Care 2008; 31: 1373-1379.
49. Watanabe K, Petro BJ, Shlimon AE, Unterman TG: Effect of periodontitis on insulin resistance and the onset of type 2 diabetes mellitus in Zucker diabetic fatty rats. J Periodontol 2008; 79: 1208-1216.
50. Mealey BL, Rose LF: Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes 2008; 15: 135-141.
51. Schulze A, Schonauer M, Busse M: Sudden improvement of insulin sensitivity related to an endodontic treatment. J Periodontol 2007; 78: 2380-2384.
52. Iwamoto Y, Nishimura F, Nakagawa M, et al: The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor- alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001; 72: 774-778.
53. Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119.
54. Membrez M, Blancher F, Jaquet M, et al: Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 2008; 22: 2416-2426.
55. Cani PD, Amar J, Iglesias MA, et al: Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
56. Cani PD, Bibiloni R, Knauf C, et al: Changes in gut microbiota control metabolic endotoxemia- induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481.
57. Roberfroid MB: Prebiotics and probiotics: are they functional foods? Am J Clin Nutr 2000; 71: 1682S-1687S.
58. Matsuzaki T, Nagata Y, Kado S, et al: Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei . APMIS 1997; 105: 643-649.
59. Matsuzaki T, Nagata Y, Kado S, et al: Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice. APMIS 1997; 105: 637-642.
60. Tabuchi M, Ozaki M, Tamura A, et al: Antidiabetic effect of Lactobacillus GG in streptozotocin- induced diabetic rats. Biosci Biotechnol Biochem 2003; 67: 1421-1424.
61. Yadav H, Jain S, Sinha PR: Oral administration of Dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocininduced diabetes in rats. J Dairy Res 2008; 75: 189-195.
62. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T: Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr J 1997; 44: 357-365.
63. Yadav H, Jain S, Sinha PR: Antidiabetic effect of probiotic Dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007; 23: 62-68.
64. Weickert MO, Pfeiffer AF: Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr 2008; 138: 439-442.
65. Cani PD, Neyrinck AM, Fava F, et al: Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50: 2374-2383.
66. Couteau D, McCartney AL, Gibson GR, et al: Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J Appl Microbiol 2001; 90: 873-881.
67. Taguri T, Tanaka T, Kouno I: Antibacterial spectrum of plant polyphenols and extracts depending upon hydroxyphenyl structure. Biol Pharm Bull 2006; 29: 2226-2235.